HMGB1 and autoimmune disease: HMGB1, IL-33, S100A7, and S100A12 were chosen as the most promising alarmins according to the literature, because they were reported to be elevated in various autoimmune diseases, yet their role in pathophysiology of psoriasis is still unclear [8, 12, 13].